EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSTRUG00000021425
Gene Symbol: ATP1A2A
1 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 3

Ensembl ID : ENSTRUG00000002904
Gene Symbol: ATP1A3
3 Cross references
135 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSTRUG00000023651
Gene Symbol: ATP1B1
2 Cross references
225 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSTRUG00000027679
Gene Symbol: ATP1B2
3 Cross references
200 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSTRUG00000000740
Gene Symbol: ATP1B3
4 Cross references
236 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSTRUG00000013854
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSTRUG00000015755
Gene Symbol: AXL
3 Cross references
187 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSTRUG00000011625
Gene Symbol: BRAF
3 Cross references
219 Possible Orthologues:

B1 Bradykinin Receptor

Ensembl ID : ENSTRUG00000013547
Gene Symbol: LOC101075438
4 Cross references
147 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSTRUG00000012724
Gene Symbol: BCL2L1
3 Cross references
209 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSTRUG00000015467
Gene Symbol: BCR
3 Cross references
196 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSTRUG00000028965
Gene Symbol: BCR
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).